Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jonathan Lass, MD
Case Western Reserve University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Georgia Eye Partners
Atlanta, Georgia, United States
- Price Vision Group
Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- Kansas City Eye Clinic
Overland Park, Kansas, United States
- Mid-Atlantic Cornea Consultants
Baltimore, Maryland, United States
- the Wilmer Eye Institute/johns Hopkins
Baltimore, Maryland, United States
- University of Michigan/kellogg Eye Center
Ann Arbor, Michigan, United States
- Verdier Eye Center
Grand Rapids, Michigan, United States
- Minnesota Eye Consultants
Bloomington, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Associated Eye Care
Stillwater, Minnesota, United States
- Moyes Eye Center
Kansas City, Missouri, United States
- Legacy Devers Eye Institute
Portland, Oregon, United States
- Ophthalmic Partners
Bala-Cynwyd, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Dec 2025
- Primary completion
- 30 Dec 2029
- Completion
- 30 Apr 2030
- Last update posted
- 27 Feb 2026
- Registered enrollment
- 570
- Registry id
- NCT07217249
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.